Analyst Ratings for Inhibrx Biosciences (INBX)
INBX Rating Summary
INBX Price Target Summary
- Highest: $325.00 (Stifel)
- Lowest: $200.00 (LifeSci Capital)
- Average: $262.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$262.50 (+182.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$262.50 (+182.1%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/24/2026 | LifeSci Capital | N/A | New Coverage | Outperform (N/A) |
200.00 (N/A) |
119.93 (93.05) |
-22.41% | Details |
| 4/7/2026 | Stifel » Updated 6/2/2026 |
Dara Azar | New Coverage | Buy (N/A) |
325.00 (N/A) |
63.72 (93.05) |
46.03% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
